355. Claudia Nari on Inari’s unique advantage + gene editing as a new paradigm in agbioscience

This is a podcast episode titled, 355. Claudia Nari on Inari’s unique advantage + gene editing as a new paradigm in agbioscience. The summary for this episode is: Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into:   <ul><li>From speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding </li><li>Crops of focus for Inari right now and stresses they’re focused on to enable farmer success </li><li>The company’s recent venture capital raise, their value proposition and educating investors </li><li>Inari’s unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time) </li><li>The status of field trials and what commercialization will look like for Inari </li><li>Biggest problems in-field to be solved through gene editing – from yield to resource efficiencies </li><li>Regulatory hurdles and Claudia’s perspective on the acceptance of gene editing as a technology </li><li>When will Inari technology be in customer fields? And what’s next? </li></ul>